GlaxoSmithKline & Tafas Win!!! PTO Loses!!!
 |
Written by Gene Quinn President & Founder of IPWatchdog, Inc. Patent Attorney, Reg. No. 44,294 Posted: April 1, 2008 @ 2:39 pm Page viewed 1,885 times 
|
 |
GlaxoSmithKline & Tafas Win!!! PTO Loses!!!
In the much anticipated decision from the Eastern District of Virginia the claims and continuation rules enjoined on October 31, 2007, were unceremoniously thrown out! Judge Cacheris concluded:
Because the USPTO’s rulemaking authority under 35 U.S.C. § 2(b)(2) does not extend to substantive rules, and because the Final Rules are substantive in nature, the Court finds that the Final Rules are void as “otherwise not in accordance with law” and “in excess of statutory jurisdiction [and] authority.” 5 U.S.C. § 706(2).
The complete decision is available at:
http://ipwatchdog.com/GSK_v_PTO/gsk_uspto_decision.pdf
Share With Friends
Related Posts
- Federal Circuit to Hear Patent Office Appeal (♥ ♥ ♥ )
- Federal Circuit to Rehear Tafas and GSK v. Doll (♥ ♥ ♥ )
- USPTO v. GSK & Tafas Chronology (♥ ♥ ♥ )
- Oral Arguments Completed in PTO v. GSK, Tafas (♥ ♥ ♥ )
- Patent Office Assault on Pharma Industry (♥ ♥ )
- Victory to the Patent Office in Claims & Continuations Appeal (♥ ♥ )
- CAFC: Wyeth and Elan Pharma Win A+B Patent Term Adjustment (♥ ♥ )
- Reexamination of Patents Listed in the FDA's Orange Book: Surprising Facts For Brands and Generics (♥ ♥ )
- Patent Wishes for the New Year (♥ ♥ )
- FDA Approves Patented Gel for Treating Acne (♥ ♥ )
Tags & Categories
Posted in: IP News, IPWatchdog.com Blog, Patent Fools™, Pharma
